-
公开(公告)号:US20240335827A1
公开(公告)日:2024-10-10
申请号:US18573316
申请日:2022-06-23
CPC分类号: B01J31/2273 , B01J37/00 , C07F7/0876 , C07F15/02 , B01J2231/323 , B01J2531/842
摘要: There is provided an iron-based complex of formula (IA) or (IB) or a solvate thereof (IA) (IB). The iron-based complex can be used for catalyzing a hydrosillation reaction, such as the hydrosilylation of a ketone or an aldehyde. Also provided is a method for preparing a silyl ether from a ketone or an aldehyde comprising the hydrosilylation of the ketone or aldehyde in the presence of the iron-based complex. Another method is provided for the synthesis of an alcohol from a ketone or an aldehyde comprising the hydrosilylation of the ketone or aldehyde in the presence of the iron-based complex to form a silyl ether, and then hydrolyzing the silyl ether to obtain the alcohol. A process for preparing the iron-based complex is further disclosed.
-
2.
公开(公告)号:US20240278207A1
公开(公告)日:2024-08-22
申请号:US18568156
申请日:2022-06-06
发明人: Dinesh Mullangi , Zeyu Deng , Yuxiang Wang , John Wang , Pieremanuele Canepa , Dan Zhao , Anthony Kevin Cheetham , Fengxia Wei
CPC分类号: B01J20/226 , B01D53/04 , B01J20/28061 , B01J20/28064 , B01J20/3483 , B01J20/3491 , C07F5/061 , C07F15/02 , B01D2257/104 , B01D2257/504
摘要: Discloses herein is an activated metal-organic framework of formula as defined in the application, and the metal organic framework has a BET surface area of from 250 to 1,000 m2/g as obtained from a 298 K CO2 sorption isotherm. In a particular embodiment, the activated metal-organic framework is aluminium formate (Al(HCOO)3) or vanadium formate (V(HCOO)3).
-
公开(公告)号:US12065452B2
公开(公告)日:2024-08-20
申请号:US17204953
申请日:2021-03-18
申请人: Tongji University
发明人: Ying Wang , Fengting Li , Bincheng Xu
CPC分类号: C07F15/02 , C01B32/21 , C02F1/46109 , C02F1/4672 , C02F2001/46142 , C02F2101/30 , C02F2305/026
摘要: A preparation method and use of a graphite felt (GF)-supported metal-organic framework (MOF) cathode material is disclosed. The preparation method includes the following steps:
preparing an iron salt, Pluronic F127, a weak acid, 2-aminoterephthalic acid, and a carbon felt; adding the iron salt and Pluronic F127 to deionized water and stirring a resulting mixture; adding the weak acid and 2-aminoterephthalic acid to the mixture, and stirring a resulting mixture to obtain an MOF precursor solution; adding the MOF precursor solution together with a pretreated carbon felt to a reactor, and sealing the reactor for hydrothermal reaction; and washing and vacuum drying a reaction product to obtain the cathode material. With a porous structure and a large specific surface area (SSA), the cathode material significantly increases the output of H2O2 when used in an electric Fenton system.-
4.
公开(公告)号:US11911519B2
公开(公告)日:2024-02-27
申请号:US17150037
申请日:2021-01-15
申请人: SOONCHUNHYANG UNIVERSITY INDUSTRY ACADEMY COOPERATION FOUNDATION , KOREA INSTITUTE OF CERAMIC ENGINEERING AND TECHNOLOGY
发明人: Jong Min Lim , Daekyung Sung , Won II Choi , Hyeon Woo Han , Sehee Jeong , Yoonhee Na , Jiseob Woo
IPC分类号: A61K9/00 , A61K9/51 , B01F23/40 , B01F23/451 , B01F25/31 , B01F35/71 , C07F15/02 , F16L41/02 , F16L41/03 , B01F25/00 , B01F101/00
CPC分类号: A61K9/5192 , A61K9/5123 , B01F23/451 , B01F23/49 , B01F25/311 , B01F35/71761 , C07F15/02 , F16L41/021 , F16L41/03 , B01F2025/916 , B01F2101/2204 , B01F2215/0459
摘要: A device for producing nanoparticles includes: a first connector comprising a first supply tube fitting member, a second supply tube fitting member, and a first discharge tube fitting member; a first tube having one side connected to the first supply tube fitting member; a second tube having one side connected to the second supply tube fitting member; a first conduit having one side connected to the first discharge tube fitting member; a first supply connected to another side of the first tube to supply a first material to the first conduit; and a second supply connected to another side of the second tube to supply a second material to the first conduit.
-
公开(公告)号:US11642650B2
公开(公告)日:2023-05-09
申请号:US17319848
申请日:2021-05-13
CPC分类号: B01J20/226 , B01J20/3425 , C01B39/00 , C07F7/00 , C07F15/02
摘要: This invention relates to a method of using MOF adsorbents to remove elemental impurities from feed streams comprising active pharmaceutical ingredients (API). The process involves contacting the feed stream comprising API and elemental impurities with the MOF at purification conditions to obtain a purified stream with provides an API which has a concentration of the elemental impurity below its permitted daily exposure. The process can be carried in a batch mode where the MOF and feed stream are admixed in a vessel for a given amount of time or continuously by flowing the feed stream through a column or adsorbent bed containing the MOF adsorbent.
-
公开(公告)号:US20190031697A1
公开(公告)日:2019-01-31
申请号:US16151446
申请日:2018-10-04
IPC分类号: C07F15/02 , C07C45/50 , B01J35/02 , C07C201/12 , B01J35/00 , B01J31/28 , B01J31/22 , C07C2/86 , C07C41/30 , C07F17/02 , C07C17/269 , C07C47/228 , C07C47/24 , C07C47/277 , C07C15/52 , C07C43/215 , C07C25/24 , C07C205/16 , C07C205/44
CPC分类号: C07F15/02 , B01J23/745 , B01J23/8906 , B01J31/1625 , B01J31/2295 , B01J31/2414 , B01J31/28 , B01J35/0013 , B01J35/0033 , B01J37/0203 , B01J37/343 , B01J2231/321 , B01J2231/4261 , B01J2531/822 , B01J2531/824 , B01J2531/842 , B01J2540/66 , C07C2/861 , C07C17/269 , C07C41/30 , C07C45/50 , C07C45/505 , C07C201/12 , C07C2531/22 , C07C2531/28 , C07F17/02 , C07C47/228 , C07C47/24 , C07C47/277 , C07C15/52 , C07C43/215 , C07C25/24 , C07C205/16 , C07C205/44
摘要: A functionalized magnetic nanoparticle including an organometallic sandwich compound and a magnetic metal oxide. The functionalized magnetic nanoparticle may be reacted with a metal precursor to fol in a catalyst for various C—C bond forming reactions. The catalyst may be recovered with ease by attracting the catalyst with a magnet.
-
公开(公告)号:US20180254478A1
公开(公告)日:2018-09-06
申请号:US15903553
申请日:2018-02-23
发明人: Simon C. Jones , Emmanuelle Despagnet-Ayoub , Brendon McNicholas , Harry B. Gray , Robert H. Grubbs
CPC分类号: H01M4/368 , C07F11/00 , C07F13/00 , C07F15/02 , C07F15/06 , H01M4/9008 , H01M8/0202 , H01M8/188 , H01M2300/0025 , Y02E60/528
摘要: In an aspect, a redox flow battery comprises a catholyte and an anolyte; wherein at least one of said catholyte and said anolyte is a metal-coordination complex, said metal-coordination complex comprising: (i) a metal; (ii) one or more first ligands coordinated with said metal atom, wherein each of said first ligands is independently a Lewis basic ligand; and one or more second ligands associated with said one or more first ligands, wherein each of said second ligands is independently a Lewis acid ligand; and a nonaqueous solvent, wherein said catholyte, said anolyte or both are dissolved in said nonaqueous solvent. One or more first ligands may be provided in a primary coordination sphere of said metal-coordination complex and one or more second ligands may be provided in a secondary coordination sphere of said metal-coordination complex. The one or more first ligands independently may comprise a Lewis basic functional group and each of said one or more second ligands independently may comprise a Lewis acidic functional group.
-
公开(公告)号:US20180243732A1
公开(公告)日:2018-08-30
申请号:US15556935
申请日:2016-03-08
发明人: Hideo NAGASHIMA , Yusuke SUNADA , Mina SAWANO , Daisuke NODA , Koji SAKUTA
IPC分类号: B01J31/16 , C07F15/02 , C07F7/18 , C07C5/03 , C07C67/303 , C07C209/50
CPC分类号: B01J31/1608 , B01J31/22 , B01J2231/323 , B01J2531/842 , C07B61/00 , C07C5/03 , C07C9/15 , C07C9/16 , C07C13/10 , C07C13/18 , C07C13/465 , C07C15/073 , C07C15/18 , C07C67/303 , C07C69/24 , C07C209/50 , C07C211/04 , C07C2531/22 , C07C2601/08 , C07C2601/14 , C07C2602/08 , C07F7/10 , C07F7/1876 , C07F15/02 , C07F19/00
摘要: A mononuclear iron bivalent complex having iron-silicon bonds, which is represented by formula (1), can exhibit an excellent catalytic activity in at least one reaction selected from three reactions, i.e., a hydrosilylation reaction, a hydrogenation reaction and a reaction for reducing a carbonyl compound. (In the formula, R1 to R6 independently represent a hydrogen atom, an alkyl group which may be substituted by X, or the like; X represents a halogen atom, or the like; L1 represents at least one two-electron ligand selected from an isonitrile ligand, an amine ligand, an imine ligand, a nitrogenated heterocyclic ring, a phosphine ligand, a phosphite ligand and a sulfide ligand, wherein, when multiple L1's are present, two L1's may be bonded to each other; L2 represents a two-electron ligand that is different from a CO ligand or the above-mentioned L1, wherein, when multiple L2's are present, two L2's may be bonded to each other; and m1 represents an integer of 1 to 4 and m2 represents an integer of 0 to 3, wherein the sum total of m1 and m2 (i.e., m1+m2) satisfies 3 or 4.)
-
公开(公告)号:US20180169641A1
公开(公告)日:2018-06-21
申请号:US15578054
申请日:2016-06-03
发明人: Salvatore BALDINO , Walter BARATTA , Andrew BLACKABY , Richard Charles BRYAN , Sarah FACCHETTI , Vaclav JURCIK , Hans Guenter NEDDEN
CPC分类号: B01J31/189 , B01J31/2273 , B01J2231/643 , B01J2231/645 , B01J2531/0244 , B01J2531/0255 , B01J2531/821 , B01J2531/825 , B01J2531/842 , C07B31/00 , C07B41/02 , C07C29/14 , C07D221/10 , C07F15/002 , C07F15/0046 , C07F15/02
摘要: The present invention provides substituted tridentate benzo[h]quinoline ligands and complexes thereof. The invention also provides the preparation of the ligands and the respective complexes, as well as to processes for using the complexes in catalytic reactions.
-
公开(公告)号:US09913821B2
公开(公告)日:2018-03-13
申请号:US15143987
申请日:2016-05-02
IPC分类号: A61K31/295
CPC分类号: C07F15/025 , A61K31/295 , C07C51/41 , C07C51/412 , C07C51/418 , C07C59/265 , C07F15/02 , C07C55/10 , C07C59/255 , C07C53/08 , C07C59/245 , C07C57/15
摘要: The present invention discloses a novel form of ferric organic compounds, including a form of ferric citrate, which are soluble over a wider range of pH, and which have a large active surface area. The ferric organic compounds of the present invention can be delivered effectively by oral route with better delivery to treat patients suffering from hyperphosphatemia, metabolic acidosis and other disorders responsive to ferric organic compound therapy.
-
-
-
-
-
-
-
-
-